Evaluating the sensitivity, stability, and cross-reactivity of commercial fentanyl immunoassay test strips

被引:4
|
作者
Rodriguez-Cruz, Sandra E. [1 ,2 ]
机构
[1] Drug Enforcement Adm, Special Testing & Res Lab, Dulles, VA USA
[2] Drug Enforcement Adm, Special Testing & Res Lab, 22624 Dulles Summit Ct, Dulles, VA 20166 USA
关键词
fentanyl; fentanyl test strips; fentanyl-related substance; harm reduction; lateral-flow immunoassay; opioid epidemic; seized drugs;
D O I
10.1111/1556-4029.15332
中图分类号
DF [法律]; D9 [法律]; R [医药、卫生];
学科分类号
0301 ; 10 ;
摘要
Illicit fentanyl has flooded the United States' drug market, increasing the risk of overdose and poisonings throughout the general population and accidental exposure among law enforcement officers confiscating the increasing number of seizures. Fentanyl test strips (FTS) are used to obtain presumptive information about the presence of fentanyl in a suspected sample. However, their adoption by law enforcement personnel and seized-drug analysts has been limited because most products are advertised for urine testing, not for assays using water solutions. This study presents an evaluation of four commercial FTS: Rapid Response from BTNX, Inc.; T-Dip Fentanyl (FTY) Urine Dip Cards obtained from ; Premier BioDip FYL10 from Premier Biotech Inc.; and MobileDetect Fentanyl strips from DetectaChem, Inc. Performance characteristics curves were used to compare the products' sensitivity, showing that all can reliably detect fentanyl in aqueous solutions at concentrations below 1 & mu;g/mL, with some of the tests able to reliably detect the drug at 200 ng/mL. A stability study demonstrates the performance of all four FTS brands was only slightly affected after 30 days of storage at two extreme environmental conditions. Fentanyl-related substances are also evaluated using the Rapid Response FTS, which showed high cross-reactivity with para-fluorofentanyl and acetylfentanyl, but lower with ortho-chlorofentanyl, carfentanil, and 4-ANPP. Users should be aware that FTS may give false-negative results even when potentially dangerous levels of carfentanil are present. When testing other common drugs, adulterants, and diluents frequently encountered in seized tablets, concentration-dependent results were obtained and multiple instances of false positives were recorded.
引用
收藏
页码:1555 / 1569
页数:15
相关论文
共 50 条
  • [41] Development of an Abbott ARCHITECT cyclosporine immunoassay without metabolite cross-reactivity
    Brate, Elaine M.
    Finley, David M.
    Grote, Jonathan
    Holets-McCormack, Shelley
    Ozaeta, Pan F.
    Pacenti, David
    Peart, Joan E.
    Piktel, Ryan E.
    Ramsay, Carol S.
    Rupprecht, Kevin R.
    Saldana, Sylvia C.
    Spring, Thomas G.
    Tetin, Sergey Y.
    Trudeau, Beth C.
    Wang, Phil
    Xie, Helen
    CLINICAL BIOCHEMISTRY, 2010, 43 (13-14) : 1152 - 1157
  • [42] HAZARD OF COMMERCIAL ANTISERUM CROSS-REACTIVITY IN MONOCLONAL GAMMOPATHY EVALUATION
    REGISTER, LJ
    KEREN, DF
    CLINICAL CHEMISTRY, 1989, 35 (09) : 2016 - 2017
  • [43] Oxaprozin cross-reactivity in three commercial immunoassays for benzodiazepines in urine
    Fraser, AD
    Howell, P
    JOURNAL OF ANALYTICAL TOXICOLOGY, 1998, 22 (01) : 50 - 54
  • [44] A STUDY OF ANTISTREPTOCOCCAL TITERS AND CROSS-REACTIVITY OF COMMERCIAL FLUORESCENT ANTISERA
    BEATTY, EC
    PEASE, NMF
    SMITH, RE
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 1968, 50 (03) : 391 - &
  • [45] Impact of pH on the Stability and the Cross-Reactivity of Ochratoxin A and Citrinin
    Bazin, Ingrid
    Faucet-Marquis, Virginie
    Monje, Marie-Carmen
    El Khoury, Micheline
    Marty, Jean-Louis
    Pfohl-Leszkowicz, Annie
    TOXINS, 2013, 5 (12) : 2324 - 2340
  • [46] Evaluation of sensitivity, specificity and cross-reactivity in Bartonella henselae serology
    Vermeulen, Marijn J.
    Verbakel, Harold
    Notermans, Daan W.
    Reimerink, Johan H. J.
    Peeters, Marcel F.
    JOURNAL OF MEDICAL MICROBIOLOGY, 2010, 59 (06) : 743 - 745
  • [47] CROSS-REACTIVITY OF DIGITOXIN IN RADIOIMMUNOASSAY AND ENZYME-LINKED IMMUNOASSAY FOR DIGOXIN IN PLASMA
    SCHERRMANN, JM
    BOURDON, R
    CLINICAL CHEMISTRY, 1980, 26 (05) : 670 - 671
  • [48] DIGOXIN IMMUNOASSAY WITH CROSS-REACTIVITY OF DIGOXIN METABOLITES PROPORTIONAL TO THEIR BIOLOGICAL-ACTIVITY
    MILLER, JJ
    STRAUB, RW
    VALDES, R
    CLINICAL CHEMISTRY, 1994, 40 (10) : 1898 - 1903
  • [49] Histoplasmosis-associated cross-reactivity in the BioRad Platelia Aspergillus enzyme immunoassay
    Wheat, L. Joseph
    Hackett, Emily
    Durkin, Michelle
    Connolly, Patricia
    Petraitiene, Ruta
    Walsh, Thomas J.
    Knox, Kenneth
    Hage, Chadi
    CLINICAL AND VACCINE IMMUNOLOGY, 2007, 14 (05) : 638 - 640
  • [50] Assessment of endogenous, oral and inhaled steroid cross-reactivity in the Roche cortisol immunoassay
    Stokes, F. J.
    Bailey, L. M.
    Ganguli, A.
    Davison, A. S.
    ANNALS OF CLINICAL BIOCHEMISTRY, 2014, 51 (04) : 503 - 506